Esgen Acquisition Corp. (ZEO)
NASDAQ (CM) NASDAQ (CM) Primary 
CXA 
Zeo Stock Falls 49.5% Despite Reporting Narrower Y/Y Loss in Q2
ZEO's Q2 revenues decline y/y on fewer solar installations, while higher labor and domestic-content material costs compress the gross margin.
ZEO Q1 Loss Narrows Y/Y, Revenues Jump 50% Despite Margin Pressure
Zeo Energy posts strong y/y revenue growth in Q1 as solar installations surge, while lower expenses help narrow losses and improve EBITDA.
ZEO Stock Slides 4.4% as Q4 Loss Widens Y/Y Despite Stable Revenues
Zeo Energy shares slump as rising y/y costs and wider losses overshadow stable revenues, while management bets on 2026 growth and expansion into new markets.
Zacks Initiates Coverage of Zeo Energy With Neutral Recommendation
Discover why Zacks, the first on Wall Street to initiate coverage, rates ZEO as "Neutral." Explore how ZEO is driving margin expansion, entering an earnings inflection and expanding into commercial solar markets.
ZEO ScientifiX and Exotropin Join Forces to Launch a Solution to Address the Growing Unmet Need for Hair Loss
FORT LAUDERDALE, FL / ACCESSWIRE / November 13, 2024 / ZEO ScientifiX, Inc. ("ZEO" or the "Company") (OTCQB:ZEOX), a South Florida-based clinical-stage biopharmaceutical company, announced it has partnered with its affiliate Exotropin, LLC, a privately-held company that produces cosmetics, nutraceuticals, and other consumer products to design and deliver a hair growth solution for people who have considered hair transplant surgery. The companies will introduce their first planned collaborative product, ZEO HAIR GROW™ Powered By Exotropin™, at the Medical Aesthetics Professionals (MAP) meeting being held in Scottsdale, Arizona, from November 14 - 16, 2024.
ZEO ScientifiX, a Leading South Florida Biotechnology Company, Launches Regenerative Medicine Educational Series for Physicians
Events Hosted By ZEO ScientifiX Offer Providers Practical Business Tools Along With Science And Research Insights FORT LAUDERDALE, FL / ACCESSWIRE / October 15, 2024 / ZEO ScientifiX, Inc. ("ZEO" or the "Company") (OTCQB:ZEOX), a South Florida-based clinical-stage biopharmaceutical company, announced the launch of a monthly educational event for healthcare providers and members of their staff. The in-person events, titled "The Future of Biologic Medicine: Expert-Led Discussions and Case Studies," provide physicians the opportunity to learn about the science of regenerative medicine, with special emphasis on current research efforts surrounding the therapeutic potential of extracellular vesicles and innovative autologous biologics.
ZEO ScientifiX Partners with National Provider of Healthcare Services
Physicians Group, LLC's Network Of Clinics And Diverse Patient Population Will Provide ZEO With Exclusive Research-Based Opportunities FORT LAUDERDALE, FL / ACCESSWIRE / October 1, 2024 / ZEO ScientifiX, Inc. ("ZEO" or the "Company") (OTCQB:ZEOX), a clinical-stage biopharmaceutical company, announced that it has recently partnered with Physicians Group, LLC ("Physicians Group"), a multi-state provider organization that together with its affiliated entities operates 75 clinics and employees over 750 clinical personnel treating between 1,500 - 2,000 patients per month, many of whom seek care for musculoskeletal conditions. ZEO ScientifiX Logo ZEO and Physicians Group intend to collaborate on future clinical trials that will focus on certain health indications commonly seen by Physicians Group's doctors whereby ZEO's products demonstrate greater therapeutic benefit than currently available treatments.
